ReviewFrontiers in immunology2026

Advances in tumor necrosis factor-α inhibitors for the treatment of juvenile idiopathic arthritis-associated uveitis.

Hanbing Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.